Nature's Bounty, Inc. et al, 60 Fed. Reg. 25218 (May 11 1995)

Products sold to treat certain symptoms, such as hair loss in men, may attract the attention of the Food and Drug Administration as well as the FTC.


Nature's Bounty agreed to stop manufacturing products and selling them with names that implied the product treated the common symptoms unless Nature's Bounty had competent and reliable scientific evidence to substantiate their claims. Further, Nature's Bounty was enjoined from marketing a product to treat, cure or curtail hair loss or promote hair growth where hair has already been lost unless the product was the subject of a new drug application to the FDA. Nature's Bounty also agreed to pay $250,000 to the FTC.

Full case and case summary also available online at:

LOADING PDF: If there are any problems, click here to download the file.

Reference Info:Federal, Federal Circuit | United States

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Babener & Associates | Attorney Advertising

Written by:


Babener & Associates on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.